Home / Recalls / Mayne Pharma Inc / D-0998-2020

D-0998-2020 Class II Terminated

Recalled by Mayne Pharma Inc — Greenville, NC

Recall Details

Product Type
Drugs
Report Date
March 18, 2020
Initiation Date
March 2, 2020
Termination Date
October 28, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8274 100-count bottles

Product Description

Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01

Reason for Recall

Product Mix-Up: A foreign tablet was found in bottle.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lot: FG11514 Exp. 05/2021

Other recalls by Mayne Pharma Inc

  • D-1152-2022 Class II — Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per C (June 9, 2022)
  • D-0387-2022 Class II — Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, D (January 14, 2022)
  • D-1129-2018 Class III — Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Onl (August 21, 2018)
  • D-0616-2018 Class III — Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Ph (March 21, 2018)
  • D-0098-2018 Class II — Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distribute (November 9, 2017)